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Membranous nephropathy is an autoimmune-mediated
glomerulonephritis and a major cause of nephrotic
syndrome. We studied the kinetics of adaptive immunity in
the pathogenesis of membranous nephropathy in T1/T2
double transgenic mice (T1/T2 TG mice) that express human
Thy1 protein under the control of interferon-c (INF-c) and
mouse Thy1.1 protein under the control of interleukin (IL)-4.
Nephropathy was induced by cationic bovine serum albumin.
We found that splenocytes expressed a progressive Th2
response and a subsequent compensatory T-helper 1 (Th1)
response, with a gradual augmentation of IL-4-producing Th2
cells and INF-c-producing Th1 cells. Increased Th2 marker
expression was seen in peripheral blood and kidney cells,
with the immunoglobulin G1 (IgG1) antibody isotype
predominant in the serum and kidneys. We found that CD8þ
T cells contribute more to the augmented INF-c production
than CD4þ T cells. Moreover, CD19þ B cells demonstrated a
greater production of IL-4 than the CD4þ T cells. Cytokine-
related gene expression in kidneys and splenocytes showed
an upregulation of proinflammatory Th1 and Th2 cytokines.
Th2 cells but not Th1 cells were significantly correlated with
serum cholesterol and proteinuria. Our study shows that
both peripheral and renal immune reactions are strongly
polarized toward Th2-type immune responses during the
course of membranous nephropathy. The T1/T2 mouse
model may help decipher the kinetic changes of adaptive
immunity in glomerulonephritis.
Kidney International (2007) 72, 831–840; doi:10.1038/sj.ki.5002426;
published online 11 July 2007
KEYWORDS: membranous nephropathy; immunology and pathology;
glomerulonephritis; proteinuria
Membranous glomerulonephropathy (MN), characterized by
an in situ immune complex disposition over the subepithelial
space and the most prevalent cause of nephrotic syndrome in
adult humans, has been recognized as an autoimmune-
mediated glomerulonephritis (GN).1,2 Earlier studies using
monoclonal antibodies to T-cell subsets indicate that T cells
are central to the induction and glomerular injury in
Heymann nephritis (HN), a rat model of idiopathic MN.3–5
The T-lymphocyte-derived cytokines also regulate the cellular
and humoral immune responses to nephritogenic antigens
and modulate inflammatory events.6,7 However, the role of
adaptive immunity in the mediation of glomerular injury in
MN has not yet been fully elucidated.
It is widely recognized that CD4þ T cells can be
differentiated into two subsets, T-helper 1 (Th1) and Th2,
according to their cytokine profiles.8,9 Th1 cells produce
cytokines such as interleukin (IL)-2, interferon g, and tumor
necrosis factor a to promote cell-mediated immunity. Th2
cells producing IL-4, IL-5, IL-10, and IL-13 can suppress Th1
cell activation and contribute to humoral immunity.10 Th1
and Th2 subsets are regulated reciprocally to maintain a
balance, which plays an important role in immune-mediated
GN.11 Th1 and Th2 subsets direct diverging effector pathways
and lead to different patterns of injury and outcomes in GN.
Th1-predominant responses are strongly associated with
proliferative and crescentic forms of GN, while Th2 responses
are associated with membranous patterns of injury.12,13
Studies involving patients with idiopathic MN showed a
consistently negative response for delayed-type hypersensiti-
vity (DTH) effectors, an increase in IL-4 production by
peripheral T-helper (Th) cells; and a predominance of
immunoglobulin G4 (IgG4) (Th2-type subclass), as well as
complement deposition in glomeruli, suggesting a Th2
response.14–17 However, the progressive development of
infiltrates of activated T cells—principally Th1 and cytotoxic
effector cells—as well as macrophages within glomeruli,
coincides with the development of proteinuria in HN. This
suggests that Th1 cells participate in the glomerular injury
and proteinuria of MN.3
Current assessment of Th1/Th2 polarization is based
primarily on cytokines produced by peripheral blood
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mononuclear cells or from Ig isotypes deposited in
glomeruli.18 However, using this approach, it is difficult to
demonstrate Th1/Th2 differentiation in vivo, and to monitor
or to quantify the Th1 and Th2 due to the lack of surface
markers. T1/T2 double transgenic mice (T1/T2 TG mice)
bear two transgenes that express two distinct cell surface
markers: the human Thy1 protein (human CD90) under the
control of murine interferon g (IFN-g), and the murine
Thy1.1 protein (murine CD90.1) under the control of murine
IL-4.19,20 We first combined the murine MN model induced
by cationic bovine serum albumin (cBSA), as previously
reported by our groups,21 and the T1/T2 TG mice, to
investigate the immunoregulatory and immunopathological
processes involved in MN, and further understand the onset
of adaptive immunity during cBSA-induced MN in vivo.
RESULTS
Establishment of an MN model in T1/T2 TG mice
T1/T2 TG mice were inbred and screened routinely as
previous. The kinetics of the development of proteinuria in
mice are showed in Figure 1a. A total of 100% of immunized
mice developed MN since week 5 and the MN mice showed
overt proteinuria, hypoalbuminemia, and hypercholesterole-
mia characteristically (Figure 1b–e). Renal histopathology
revealed typical morphology of membranous nephropathy as
glomerular basement membrane thickening, IgG granular
deposition, and subepithelial deposits seen in hematoxylin
and eosin, immunofluorescent (IF), and electron microscopy
(EM) sections (Figure 1f–h). There were no significant
differences between the MN mice of the BALB/c strain and
the T1/T2 TG mice (data not shown).
Kinetic changes in major lymphocyte subsets in spleens
To investigate the kinetics of the immune response during
MN, we analyzed the numbers and subpopulations of splenic
lymphocytes subsets at different times points after immuni-
zation (weeks 0, 2, 4, 6, 8). The numbers of splenic
lymphocytes increased progressively (Figure 2a). The abso-
lute numbers of CD4þ and CD8þ T cells showed reciprocal
increased as total splenocytes, despite relative consistent
proportion (Figure 2b and c). We also observed a progressive
increase in the proportion and absolute numbers of CD19þ
B cells in the MN mice from week 2; this peaked at week 4
and remained high throughout the MN process (Figure 2d).
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Figure 1 | Clinical manifestations and renal histopathology in T1/T2 TG mice with MN. (a) The kinetics of the development of
proteinuria at different time points are shown. (b–e) The biochemical findings in MN mice revealed normal renal function, hypoalbuminemia,
hypercholesterolemia, and overt proteinuria. Histopathology revealed findings characteristic of diffuse basement membrane thickening,
as observed in the (f) hematoxylin and eosin staining, (g) positive granular immunofluorescent staining for IgG, and (h) subepithelial
deposition (asterisk). NC, normal control; MN, membranous nephropathy; G, glomerular basement membrane; L, lumen of capillary; P,
podocyte; and U, urinary space (n¼ 12).
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Kinetic changes in Th1 cells (CD4þhCD90þ ) and Th2 cells
(CD4þmCD90.1þ )
To verify the complex Th1/Th2 paradigm during MN, we
examined the kinetic expression of transgenes on CD4þ
T cells, to identify them as either Th1 cells (hCD90 under the
control of the IFN-g promoter on CD4þ T cells) or Th2 cells
(mCD90.1 under the control of the IL-4 promoter on CD4þ
T cells) using T1/T2 TG mice. The Th1 reporter/Th2 reporter
signals on total splenocytes and gated on CD4 T cell can be
clearly demonstrated by flow cytometry (Figure 3a). Two
weeks after immunization, the MN mice had a significant
increase in splenic Th2 cells and then a progressive increase in
splenic Th2 cells (Figure 3c). This indicates an extended Th2
response at this point. We also noticed a trend of increase in
the percentage of Th1 cells from week 6 (Figure 3b). We
noted that CD8þ T cells formed most of the remaining
Th1þ cells. To rule out the possibility that the Th1þ cell
population contained other IFN-g-producing NK cells, we
costained cells with anti-DX5. We found that the percentage
of DX5þ cells in the MN mice did not differ from that in the
controls. Moreover, there were very few cells expressing
hCD90 and DX5 markers simultaneously, suggesting that
most of the Th1þ cells were T-lymphocytes (data not
shown). The expression levels of Th1 and Th2 cells among
peripheral mononuclear blood cells from MN mice at week 8
showed similar results (Figure 3d). To confirm whether what
happening with the T cells in the spleen is also happening in
the kidneys, we checked the expression of Th1/Th2 reporter
in the kidneys by using quantitative real-time polymerase
chain reaction (RT-PCR) at various time points. The Th1
reporter/Th2 reporter status of kidney revealed parallel
changes with those in the spleen (Figure 3e). Taken together,
these results imply a progressive Th2-prone process of
adaptive immunity during experimental MN.
Immunohistochemistry for hCD90, mCD90.1, and CD4
in kidneys
To further investigate the distribution of Th1 and Th2 cells in
kidneys, we performed immunohistochemical staining for
hCD90, mCD90.1, and CD4 in the kidneys from normal
control (NC) (Figure 4a–c) and MN (Figure 4d–f) mice, to
identify and localize the Th cells. The hCD90þ cells were
noted in both groups, however, there were more hCD90þ
cells noted in MN kidney (Figure 4a and d). In contrast to
hCD90, there were no mCD90.1þ cells noted in NC kidney,
but prominent mCD90.1þ cells were noted in MN mice
(Figure 4b and e). There were very scanty CD4þ cells noted
in NC kidney, and the number increased in MN kidney
(Figure 4c and f). The dissociated expression between hCD90
and CD4 may suggest that the predominant source of IFN-g
production were not Th1 cells, but the resident renal cells,
especially during MN condition. The prominent and parallel
expression between the mCD90.1þ and CD4þ cells may
imply the Th2 polarization in renal T cell during MN.
Serum Igs production and subclass
The Th1 and Th2 subsets can be differentiated according to
the production of individual cytokines. Th1 regulates Ig
switching to the IgG2a subtype, whereas Th2 enhances IgG1
secretion. We found that the titers of anti-cBSA antibodies—
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Figure 2 | Distributions of lymphocyte subsets in spleens after MN induction. The distribution kinetics of (a) total splenocytes, (b) CD4þ
T cells, (c) CD8þ T cells, and (d) CD19þ B cells were shown at selected times post-MN induction in T1/T2 transgenic mice. Values are
means7s.ds. *Po0.05 versus NC (n¼ 5).
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Figure 3 | Development of Th1/Th2 cells in T1/T2 TG mice. Splenic lymphocytes of transgenic mice were stained with marker-specific
antibodies for flow cytometric analysis: phycoerythrin-conjugated anti-hThy1 (T1), fluorescein isothiocyanate-conjugated anti-mThy1.1 (T2),
and allophycocyanin-conjugated anti-mouse CD4. (a) The T1/T2 reporter signals on total splenocytes from MN mice at week 4 and gated on
CD4 T cell were clearly demonstrated by flow cytometry. The proportions of (b) Th1 (CD4þhThy1þ T) cells and (c) Th2 (CD4þmThy1.1þ T) cells
in the spleens were analyzed at selective times post-MN induction. (d) The percentages of Th1 and Th2 cells in peripheral blood mononuclear
cells from MN mice at week 8 were also measured. (e) The T1/T2 reporter status of the kidneys revealed parallel changes to those in the spleen.
Values are means7s.ds. *Po 0.05 versus normal controls (n¼ 5).
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Figure 4 | Immunohistochemistry for hCD90, mCD90.1, and CD4 in kidneys. Kidneys from mice of (a–c) normal controls (d–e) and
membranous nephropathy group were stained with anti-hCD90 (a and d), anti-mCD90.1 (b and e), and anti-CD4 (c and f) at week 8. Positive
staining for hCD90, mCD90.1, and CD4 is indicated by short arrows.
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mostly IgG1—increased from week 2 and peaked at week 4.
Serum level of Igs at weeks 6 and 8 were lower than at week 4.
These findings may imply the development of tolerance and a
Th2-predominant response (Figure 5a). To investigate
whether the isotype of antibodies deposited in the kidney
parallels to the findings in sera, we further performed the
immunofluorescent staining and the result revealed a
prominent IgG1 antibody deposition in the kidney rather
than IgG2a (Figure 5b).
Lymphocyte proliferation and cytokine production after
antigen-specific stimulation
We used an H3-proliferation assay to determine the optimal
concentration of specific antigen that induced splenic T-cell
activation and proliferation. We used cBSA doses ranging from
0 to 500mg/ml as specific antigens to restimulate splenocytes
isolated from the MN mice at week 4 after induction.
Concanavalin A was also used to stimulate cultured splenocytes
as a positive control. As compared with splenocytes without
stimulation, we observed a peak of proliferation after stimula-
tion with cBSA at 1mg/ml, and significant toxicity was noted
when dosage larger than 10mg/ml (Figure 6a). However, in the
control mice, significant proliferation was detected only in
cultured splenocytes stimulated with concanavalin A, and there
was no proliferative response after cBSA stimulation. This
confirms that cBSA is a specific antigen in this MN model. We
further investigated the secretion of IFN-g and IL-4 from
splenocytes stimulated with or without cBSA. As compared to
NC mice, levels of IL-4 were increased significantly in MN mice
and cBSA restimulation may further enhance its secretion
(Figure 6b and c).
Identification of IFN-c and IL-4 in different lymphocyte
subsets
Because Th1/Th2 development during process of MN is
complicated, we cultured splenocytes from either control or
MN mice, and these were simultaneously stimulated with or
without cBSA, and stained to assess intracellular cytokine
contents (Table 1). We noted the highest percentages of both
intracellular IFN-g and IL-4 in the MN group stimulated
with cBSA, and the lowest percentage in the control group.
To clarify the characteristics of IFN-g/IL-4-related cytokine-
producing lymphocyte subsets, we examined IFN-g-produ-
cing cells among either CD4þ T cells or CD8þ T cells, and
IL-4-producing cells among either CD4þ T cells or CD19þ
B cells. We identified a significant increase in IL-4-producing
cells in the MN group without specific antigen restimulation.
However, Th1 cells were only slightly amplified. Interestingly,
lymphocyte subsets from the MN group restimulated with
specific antigens displayed a greater capacity to secrete IFN-g
and IL-4, especially among the IFN-g-producing CD8þ
T cells and IL-4-producing CD19þ B cells. Nevertheless,
CD8þ T cells contributed more to the augmented produc-
tion of IFN-g than the CD4þ T cells; moreover, CD19þ B
cells also demonstrated greater IL-4 production than the
CD4þ T cells.
Cytokine mRNA expression in splenocytes and kidney
To further understand cytokine expression during MN, we
examined mRNA from renal cortex and splenocytes. We
checked for the proinflammatory cytokines (IL-1b and
tumor necrosis factor a), Th1 cytokines (IFN-g and IL-2),
and Th2 cytokines (IL-4 and IL-10). Quantitative RT-PCR of
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Figure 5 | Serum levels of total anti-cBSA Igs IgG1 and IgG2a in cBSA-induced MN mice. (a) The total serum Igs, IgG1, and IgG2a,
were evaluated by enzyme-linked immunosorbant assay at selected times post induction. Data are expressed as optical density at 450 nm.
(b) Immunofluorescent staining further confirmed that antibody deposition in the kidneys was composed primarily of IgG1 rather than
IgG2a at different time points (n¼ 5).
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renal cortex and splenocytes demonstrated a consistent
change with slightly increased expression of proinflammatory
and Th1 cytokines and extremely high expression of Th2
cytokines (Figure 7a and b).
Correlation of Th1 and Th2 cell with clinical parameters
of MN
We analyzed the results of the Th1/Th2 cells numbers and
clinical parameters in mice with MN. We found that the Th2
CD4þ response increased as the MN progression and showed
that the number of Th2 cell not the Th1 cell significant
correlated with serum cholesterol and proteinuria (r¼ 0.53
and 0.59, Po0.05, respectively) (Figure 8a–d).
DISCUSSION
A progressive increase in Th2 cells was observed in
splenocytes as well as in peripheral blood and kidney cells.
In addition, the Th2-prone IgG1 Ig subclass was also noted in
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Figure 6 | Antigen-specific lymphocyte proliferation assays and cytokine production estimated by enzyme-linked immunosorbant
assay. cBSA was used as a specific antigen. Using splenic lymphocyte proliferation assays, RBC-depleted splenocytes (1.25 106 splenocytes/
ml) were isolated from mice at week 8 post-MN induction. (a) Various concentrations of cBSA or concanavalin A (5 mg/ml) were used to
stimulate the cultured splenocytes for determining the concentration showing maximal antigenicity. The production of cytokines in
RBC-depleted splenocytes (1.25 106 splenocytes per milliliter) harvested from normal control or MN mice at week 4 were cultured with or
without cBSA (1 mg/ml) for 48 h. Supernatants were collected for the detection of (b) IFN-g and (c) IL-4 by enzyme-linked immunosorbant assay.
Values are means7s.ds. *Po0.05 versus NC; **Po0.05 versus MN. Results shown are representative of triplicate determinations (n¼ 3).
Table 1 | Intracellular cytokine determination
% of splenocyte NC MN MN with cBSA
IFN-g+ 0.21070.079 0.53570.078a 0.85570.247a
CD4+IFN-g+ 0.05970.008 0.10270.035 0.12470.006
CD8+IFN-g+ 0.12970.045 0.40170.163a,b 0.64370.278a,b
IL-4+ 1.91570.120 2.79070.367a 3.63070.169a,c
CD4+IL-4+ 0.36070.240 0.73570.148 0.76470.076
CD19+IL-4+ 0.84070.085 1.33570.078a,b 1.69570.021a,b,c
cBSA, cationic bovine serum albumin; IFN-g, interferon-g; IL-4, interleukin-4;
NC, normal control; MN, membranous nephropathy.
Splenocytes were harvested and cultured with or without specific antigens (cBSA
1mg/ml), to detect surface markers of lymphocyte subsets and stained for
intracellular cytokines.
aPo0.05 versus NC splenocyte.
bPo0.05 versus CD4 cell.
cPo0.05 versus MN splenocyte.
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the serum and kidneys. Antigen-specific restimulation testing
of cytokine production and intracellular cytokine staining
revealed an IL-4 prominent immune response. Cytokine-
related gene expression in the kidneys and splenocytes
demonstrated enhancement of pro-inflammatory cytokines
as well as Th1/Th2 cytokines. Our data demonstrates both
the peripheral and renal immune reactions are strongly
polarized toward the Th2 type immune response in the
process of cBSA-induced MN.
The kinetic distribution of different lymphocyte subsets,
as well as the association between clinical manifestations and
the complicated course of adaptive immune responses during
MN, is not well understood. A progressive increase in the
proportion and absolute numbers of CD19þ B cells in the
MN mice during the early phase of MN, combined with the
production and deposition of IgG1-predominant anti-cBSA
Ig in the serum and kidneys, indicate that the initial immune
response primarily involves the humoral-mediated mechan-
ism. Recent studies have demonstrated that blocking the
CD20-positive B cells by rituximab, and thereby, inhibiting
B-cell differentiation and Ig secretion, can reduce proteinuria
and prevent disease progression in patients with idiopathic
MN. This further confirms the pathogenic role of B cells in
MN.22–24 In our previous study, we also found that the cBSA-
induced murine MN model is strain dependent. It can be
induced in Th2-prone BALB/c mice but not Th1-prone C57/
BL6 mice.21 In this study, we showed that the Th2 CD4þ
response, and not the Th1 CD4þ response, significantly
correlated with the progression of MN. As compared to the
finding that Th1-predominant nephritogenic immune re-
sponses are associated with severe proliferative and crescentic
GN, our findings indicate that theTh2 response may play an
important role in the development of MN and demonstrate a
strong correlational link between the Th2 immune response
and MN.
In the MN mice, production via cBSA restimulation and
subsequent staining of intracellular cytokines from cultured
splenocytes revealed a significant increase in IL-4-producing
CD4þ T cells, but only a slight increase in IFN-g-producing
CD4þ T cells. This provides further evidence confirming the
maintenance of Th2 cells post-cBSA induction. Furthermore,
data from intracellular cytokines post-Ag-specific restimula-
tion suggests that IFN-g is secreted predominantly by CD8þ
T cells, while IL-4 is secreted either by CD4þ T cells or
B cells. These results may imply that CD4þ T cells preserve
their potential Th2 capacity after MN and that CD8þ T cells
function more effectively than CD4þ T cells in the
production of IFN-g following re-exposure to antigens. In
addition to assisting in antibody production, the Th cell
subsets also affect and direct cellular immune mechanisms in
GN.6 Interestingly, we also found a later increase in Th1
expression. The activation of CD8þ T cells appears to be
much slower than that of the CD4þ T-cell-dependent B-cell
response to cBSA. Previous studies have demonstrated that
persistent depletion of CD8þ T cell both early and late in the
course of disease prevented the development of proteinuria.
In addition, it was also found that IL-4 administration before
onset of proteinuria, rather than the early rIL-4 treatment,
prevented proteinuria in HN, indicating the importance of
CD8þ T cell in mediating the final effector phase of
glomerular injury in HN.4,25 This increase in Th1 cells may
play a role in the counter-regulation of the Th2 response, and
implies an association between the characteristics of the
disease process and the kinetics of the Th1/Th2 responses
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during MN. Taken together, these findings support the idea
that the functional dichotomy between the Th1 and Th2
lymphocyte subsets play a regulatory role in the disease and
both the humoral and cell-mediated immune responses may
participate in the pathogenesis of MN.
Although inflammatory cells have been identified within
glomeruli and implicated as an important pathogenic
mechanism in Lewis rats with HN,3 only a small number
of T-lymphocytes infiltrate in cBSA-induced MN kidney. We
took advantage of the high sensitivity of RT-PCR to study the
expression of cytokine genes, in order to elucidate the
operational network of cytokines in MN.26 We demonstrated
an apparent upregulation of proinflammatory, Th1- and
Th2-type cytokine mRNA in MN. It seems that the immune
complex and consequent cascade of events, including
inflammation, complement activation and oxidative stress
etc., may all participate in the progression of the disease.27–30
The expression of anti-inflammatory cytokine IL-10, ob-
served to have been extremely enhanced in MN,31,32 can also
induce the differentiation of B cells, stimulate Ig synthesis,
promote mesangial deposition of immune complexes, and
thus contribute to the continuation of glomerular injury.
Further investigation is necessary to clarify whether its
excessive production is compensated for renoprotection or is
associated with glomerular lesions. On the other hand, the
resident renal cells are the major source of several cytokines,
and this may explain why cytokine expression level was much
higher in the renal cortex than in splenocytes in MN.31,33–35
In PCR study, we extracted total RNA from snap–frozen renal
cortex tissues, rather than using isolated glomeruli. There-
fore, discrimination between the cellular and compartmental
origins of each cytokine produced in the kidney could not be
made. Despite these limitations, this study proved to be
worthwhile because it demonstrated the interrelationships of
cytokines in MN.
There were scantily detectable numbers of hCD90þ or
mCD90.1þ cells in spleens from control T1/T2 TG, and the
transgenes were only expressed during specific immunologi-
cal responses against different antigens or pathogens, under
restricted control. However, the probable monoallelic activa-
tion of the IFN-g and IL-4 promoters may synchronize the
expression of endogenous cytokines and surface markers
incompletely.36,37 Although this limitation might affect the
precise analysis and interpretation of transgene expression
levels, it still has advantages of stable and stronger signal
expression, a wider time window for detection, lack of
requirement of restimulation or permeabilization, and
possible isolation of viable cells of given Th phenotypes.
Thus, these T1/T2 TG mice are useful in providing a feasible
and direct in vivo monitoring system for dissecting the
changes in proportions of pathogenic T cells during the
pathogenic or therapeutic processes using flow cytometry
with surface immunofluorescent staining.19,20,38
In conclusion, these data demonstrate that both peripheral
and renal immune responses are strongly polarized toward
the Th2-type immune response, in the process of cBSA-
induced MN. The T1/T2 TG mice could provide an available
model to dissect the complex kinetic changes of adaptive
immunity in GN and promises a potential strategy for
the development of immunotherapeutic strategies against
MN in the future.
MATERIALS AND METHODS
Mice
All animal studies were approved by the Animal Care and Use
Committee of National Defense Medical Center (Taipei, Taiwan).
Female BALB/c mice were purchased from the National Laboratory
Animal Center and crossed with male T1/T2 TG mice on a BALB/c
background. Genomic tail DNA was screened by PCR amplification,
as described.19
Experimental design
Six-week-old female T1/T2 TG mice were divided randomly into
following two groups: an experimental group and a control group.
Animals in the experimental group were immunized with 0.2 mg of
cBSA emulsified in an equal volume of complete Freund’s adjuvant
and those in the control group were immunized with complete
Freund’s adjuvant alone. Two weeks later, the experimental group
received cBSA (13 mg/kg) intravenously three times per week every
other day for 6 weeks, and the control group received saline alone on
the same schedule. Homogenous cBSA was prepared as described
previously.21 The animals were killed at different time frames post
immunization.
Serum and urine measurements
Urine samples were obtained weekly for proteinuria screening by
Labstix (Bayer Corp., Elkhart, IN, USA). For every urine proteinuria
concentration (in mg/dl) of 0–30, 30–100, 100–300, 300–2000, and
2000þ , a corresponding grade of 0–4 was given, respectively.
Proteinuria was also quantified by measuring the ratio of urinary
protein (mg/ml) to urinary creatinine (mg/dl) (Up/UCr). Protein
level was determined using a BCA protein assay kit (Pierce,
Rockford, IL, USA). Concentrations of blood urea nitrogen,
creatinine, albumin, and total cholesterol were determined using
commercially available kits (Roche Diagnostics, Indianapolis, IN,
USA). Serum concentrations of anti-cBSA Igs, IgG1, and IgG2a were
measured as described,39 and data were expressed as optical density
at 450 nm.
Histological examination
Formalin-fixed and paraffin-embedded sections of kidney tissues
were cut and stained with hematoxylin and eosin. Frozen sections
were air dried, fixed in acetone, and washed with phosphate-
buffered saline, before incubation with fluorescein isothiocyanate-
conjugated goat anti-mouse Ig G, IgG1, IgG2a, and C3 (Capple,
Durham, NC, USA) for immunofluorescence study.40 Ultrathin
sections were stained with uranyl acetate, followed by lead citrate,
and subsequently observed using HITACHI transmission electron
microscope H-7000 (Tokyo, Japan).
Immunohistochemistry
Immunohistochemistry was performed on frozen section that was
fixed by cold acetone. Nonspecific antibody binding, endogenous
avidin binding activity, and endogenous peroxidase activity were
blocking with normal serum, Biotin Blocking System (Dako
Corporation, Carpinteria, CA, USA) and 3% H2O2, respectively.
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Sections were then incubated with primary antibody to biotin-
conjugated anti-human CD90, anti-mouse CD90.1, or anti-mouse
CD4, followed by incubated with avidin horseradish peroxidase
complex. The reaction products were visualized by the addition of
freshly prepared diaminobenzidine tetrahydrochloride. Slides were
counterstained with hematoxylin and mounted for microscopic
examination.
Flow cytometry and intracellular cytokine staining
All monoclonal antibodies were purchased from BD Biosciences
(San Jose, CA, USA) or eBioscience (San Diego, CA, USA). Isolated
splenocytes were stained with marker-specific antibodies: fluorescein
isothiocyanate-conjugated anti-mouse CD90.1, anti-mouse CD19,
or anti-mouse DX5; phycoerythrin-conjugated anti-human CD90,
or anti-mouse CD8a; or allophycocyanin-conjugated anti-mouse
CD4. For intracellular cytokine staining, splenocytes were incubated
for 24 h with or without cBSA (1 mg/ml) for antigen-specific
restimulation, and stimulated with 20 ng/ml phorbol 12-myristate
13-acetate plus 500 ng/ml ionomycin for 4 h at 371C, the last 2 h in
the presence of monensin (2 mM; Sigma-Aldrich, St Louis, MO,
USA). Cells were then washed with phosphate-buffered saline that
contained 2% fetal calf serum, fixed and permeabilized with saponin
solution (eBioscience, San Diego, CA, USA) and incubated with
fluorescein isothiocyanate-conjugated IFN-g antibody and/or phyco-
erythrin-conjugated anti-mouse IL-4 antibody. The stained cells were
analyzed by FACS Caliber cell sorter using Cell Quest software
(Becton Dickinson, San Diego, CA, USA).
Lymphocyte proliferation assays and cytokine
determinations
Isolated splenocytes were seeded in triplicate at 1.25 106 per well
in a 96-well flat-bottomed plate (BD Biosciences). Cells were
stimulated with concanavalin A (5mg/ml; Sigma Chemical Co.,
Basel, Switzerland) or with a specific antigen (cBSA, 0–500 mg/ml)
for 72 h, or left unstimulated as negative controls. After 3 days,
cultured splenocytes were pulsed with 1 mCi per well [3H]methyl
thymidine (Amersham-Pharmacia Biotech, Buckinghamshire, UK),
overnight for 16 h. The plates were then harvested onto glass fibers,
and the incorporated [3H]methyl thymidine was detected using a
TopCount Liquid Scintillation Counter (Packard, Perkin Elmer,
Boston, MA, USA). Culture supernatants from 1.25 106 spleno-
cytes per milliliter incubated with or without cBSA for 24 h were
harvested for the detection of IFN-g and IL-4 in duplicate samples
from each animal by enzyme-linked immunosorbant assay (R&D
Systems, Minneapolis, MN, USA).
RNA extraction and real-time quantitative PCR
Total RNA from the renal cortex or splenocytes was converted to
cDNA with Superscript III Reverse Transcriptase kit (Life Technol-
ogies, Grand Island, NY, USA) following the standard protocol. RT-
PCR analyses were performed using the SYBR Green Master Mix Kit
(Bio-Rad, Hercules, CA, USA) and the Opticon PCR thermal cycler
(MJ Research, Waltham, MA, USA). The relative expression of each
mRNA was determined and normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH). Primer and probe sequences
are listed in Table 2.
Statistical analyses
All data were expressed as mean7s.d. Statistical analysis was
performed by one-way analysis of variance for multiple compari-
sons. Two group differences were analyzed by t-test. Correlation
analysis was examined by tests of linear regression. Significance was
defined as Po0.05.
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